Search all trials

Find therapies in clinical trials near you – page 15

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Plasma cell myeloma

Recruiting

Registered drugNo placebo

Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

B-cell lymphoma recurrent+1

Recruiting

Registered drugNo placebo

Study on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Oxaliplatin

Contact Research Centre

Glioblastoma

Recruiting

Registered drugNo placebo

Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years

Contact Research Centre

Systemic scleroderma+1

Recruiting

Registered drug

Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Belimumab

Contact Research Centre

Breast cancer metastatic

Recruiting

Registered drugNo placebo

Study on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Olaparib

Contact Research Centre

Malignant melanoma

Recruiting

InvestigationalNo placebo

Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Zirconium (89Zr) Crefmirlimab Berdoxam

Contact Research Centre

Prostate cancer metastatic

Recruiting

Registered drug

Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Abiraterone Acetate

Contact Research Centre

Neuroblastoma+2

Recruiting

Registered drugNo placebo

Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

Registered drugNo placebo

Germany

Participants:0–17 years · 18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Hepatocellular carcinoma

Recruiting

Registered drug

Study on the Effectiveness of Durvalumab and Bevacizumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Bevacizumab

Contact Research Centre

Parkinson's disease

Recruiting

InvestigationalNo placebo

Study on the Effects of Prasinezumab in Patients with Early Parkinson's Disease

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Prasinezumab

Contact Research Centre

Alpha-1 antitrypsin deficiency

Recruiting

Registered drug

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Fazirsiran

Contact Research Centre

Neoplasm malignant+7

Recruiting

Registered drugNo placebo

Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Find therapies in clinical trials near you – page 15

605 trials match your criteria

Plasma cell myeloma

Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

B-cell lymphoma recurrent+1

Study on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation

Glioblastoma

Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

Systemic scleroderma+1

Study on the Effects of Belimumab in Adults with Systemic Sclerosis-Associated Interstitial Lung Disease

Breast cancer metastatic

Study on Adding Elacestrant to Olaparib for Patients with HR-Positive, HER2-Negative Advanced Breast Cancer with gBRCA1/2 Mutations

Malignant melanoma

Study on Early Detection of Side Effects in Metastatic Melanoma Patients Using Zirconium (89Zr) Crefmirlimab Berdoxam Imaging

Prostate cancer metastatic

Study of AZD5305 with Abiraterone Acetate and Darolutamide in Men with Metastatic Castration-Sensitive Prostate Cancer

Neuroblastoma+2

Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

Hepatocellular carcinoma

Study on the Effectiveness of Durvalumab and Bevacizumab for Patients with Liver Cancer at High Risk of Recurrence After Surgery or Ablation

Parkinson's disease

Study on the Effects of Prasinezumab in Patients with Early Parkinson's Disease

Alpha-1 antitrypsin deficiency

Study on Fazirsiran for Patients with Alpha-1 Antitrypsin Deficiency Liver Disease and Mild Fibrosis

Neoplasm malignant+7

Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.